Brought to you by 
Menarini to co-market Orion's EasyHaler; deal expanded to include some Asian territories.
Sep 2016
Executive Summary
Orion Corp. and Menarini Group will co-market the former's budesonide/formoterol Easyhaler combination product for asthma and chronic obstructive pulmonary disease in Germany, Italy, Spain, and Portugal.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
- Generic Drugs
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- Co-Marketing
- Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Menarini to co-market Orion's EasyHaler; deal expanded to include some Asian territories.
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice